AETHLON MEDICAL INC (AEMD) Stock Price, Quote, News and Overview
NASDAQ:AEMD - Nasdaq - US00808Y4061 - Common Stock - Currency: USD
AEMD Quote, Performance and Key Statistics
0.3753
0 (-1.24%)
The current stock price of AEMD is 0.3753 USD. In the past month the price decreased by -5.47%. In the past year, price decreased by -72.06%.
AEMD Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABT | ABBOTT LABORATORIES | 27.07 | 224.39B | ||
| ISRG | INTUITIVE SURGICAL INC | 66.51 | 182.05B | ||
| BSX | BOSTON SCIENTIFIC CORP | 37.46 | 149.59B | ||
| SYK | STRYKER CORP | 29.62 | 137.81B | ||
| MDT | MEDTRONIC PLC | 15.79 | 108.12B | ||
| BDX | BECTON DICKINSON AND CO | 14.7 | 58.71B | ||
| EW | EDWARDS LIFESCIENCES CORP | 28.9 | 44.17B | ||
| IDXX | IDEXX LABORATORIES INC | 39.2 | 35.74B | ||
| RMD | RESMED INC | 26 | 34.68B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 14.94 | 30.71B | ||
| DXCM | DEXCOM INC | 42.9 | 27.75B | ||
| PHG | KONINKLIJKE PHILIPS NVR- NY | 15.65 | 23.24B |
Related stock screener links
About AEMD
Company Profile
Aethlon Medical, Inc. is a medical technology company which focuses on developing products to diagnose and treat life and organ threatening diseases. The company is headquartered in San Diego, California and currently employs 14 full-time employees. The Hemopurifier, in pre-clinical studies, has demonstrated the removal of harmful exosomes from biological fluids, utilizing its lectin-based technology. The Hemopurifier is a United States Food and Drug Administration (FDA) designated Breakthrough Device indicated for the treatment of individuals with advanced or metastatic cancer who are either unresponsive to or intolerant of standard of care therapy, and with cancer types in which exosomes have been shown to participate in the development or severity of the disease. The Hemopurifier also holds an FDA Breakthrough Device designation and an open Investigational Device Exemption application related to the treatment of life-threatening viruses that are not addressed with approved therapies.
Company Info
AETHLON MEDICAL INC
11555 Sorrento Valley Road, Suite 203
San Diego CALIFORNIA 92123 US
CEO: Charles J. Fisher Jr
Employees: 14
Company Website: https://www.aethlonmedical.com/
Investor Relations: http://ir.aethlonmedical.com
Phone: 16199410360
AETHLON MEDICAL INC / AEMD FAQ
What is the stock price of AETHLON MEDICAL INC today?
The current stock price of AEMD is 0.3753 USD. The price decreased by -1.24% in the last trading session.
What is the ticker symbol for AETHLON MEDICAL INC stock?
The exchange symbol of AETHLON MEDICAL INC is AEMD and it is listed on the Nasdaq exchange.
On which exchange is AEMD stock listed?
AEMD stock is listed on the Nasdaq exchange.
What is the price forecast or stock price prediction for AETHLON MEDICAL INC stock?
8 analysts have analysed AEMD and the average price target is 3.95 USD. This implies a price increase of 953.16% is expected in the next year compared to the current price of 0.3753. Check the AETHLON MEDICAL INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is AETHLON MEDICAL INC worth?
AETHLON MEDICAL INC (AEMD) has a market capitalization of 7.75M USD. This makes AEMD a Nano Cap stock.
How many employees does AETHLON MEDICAL INC have?
AETHLON MEDICAL INC (AEMD) currently has 14 employees.
What are the support and resistance levels for AETHLON MEDICAL INC (AEMD) stock?
AETHLON MEDICAL INC (AEMD) has a support level at 0.34. Check the full technical report for a detailed analysis of AEMD support and resistance levels.
Should I buy AETHLON MEDICAL INC (AEMD) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of AEMD, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of AEMD, evaluating the profitability, health, valuation and growth aspects
- AETHLON MEDICAL INC (AEMD) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- AETHLON MEDICAL INC (AEMD) Sales and EPS estimates to see what analysts future expectations are.
- AETHLON MEDICAL INC (AEMD) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- AETHLON MEDICAL INC (AEMD) Insider and Institutional Ownership to learn about the owners and their transactions.
- AETHLON MEDICAL INC (AEMD) Stock Chart to make your own analysis
- AETHLON MEDICAL INC (AEMD) Latest news and press-releases to stay up to date.
Does AETHLON MEDICAL INC (AEMD) stock pay dividends?
AEMD does not pay a dividend.
When does AETHLON MEDICAL INC (AEMD) report earnings?
AETHLON MEDICAL INC (AEMD) will report earnings on 2025-06-25, after the market close.
What is the Price/Earnings (PE) ratio of AETHLON MEDICAL INC (AEMD)?
AETHLON MEDICAL INC (AEMD) does not have a PE ratio as the earnings reported over the last twelve months were negative (-1.58).
What is the Short Interest ratio of AETHLON MEDICAL INC (AEMD) stock?
The outstanding short interest for AETHLON MEDICAL INC (AEMD) is 3.33% of its float. Check the ownership tab for more information on the AEMD short interest.
AEMD Technical Analysis
AEMD Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to AEMD. While AEMD seems to be doing ok healthwise, there are quite some concerns on its profitability.
AEMD Financial Highlights
Over the last trailing twelve months AEMD reported a non-GAAP Earnings per Share(EPS) of -1.58. The EPS increased by 68.34% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -127.38% | ||
| ROE | -187.24% | ||
| Debt/Equity | 0 |
AEMD Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 80% to AEMD. The Buy consensus is the average rating of analysts ratings from 8 analysts.